John C. Lantis, MD, FACS
Dr. John Lantis is a native of New York City and was born at St Lukes Hospital. He attended Davidson College where he participated extensively in intercollegiate athletics. He went on to attend Albany Medical College where he graduated Cum Laude, and was elected to Alpha Omega Alpha, the medical honor society. He then went on to complete his general surgical residency at Tufts/New England Medical Center and his vascular surgery fellowship at Brigham and Women’s Hospital.In 2000 he accepted a faculty position in Surgery at Columbia University, College of Physicians & Surgeons.
He joined the faculty at St Lukes-Roosevelt Hospital in 2004, after 4 years in practice at New York Presbyterian Hospital. In 2007 he accepted the position of the Chief of Vascular and Endovascular Surgery at St Luke’s – Roosevelt Hospital. Prior to accepting that position in 2007, he was the Director of Clinical Research for the Department of Surgery, a position he still holds. He is a Fellow of the American College of Surgeons, on the Executive Council of the New York Vascular Surgery Society, and a member of the Peripheral Vascular Surgical Society, and the Society of Vascular Surgeons.
His clinical practice includes endovascular and open limb salvage, with a multi-disciplinary approach to wound closure and limb preservation, carotid artery surgery and stenting, endovascular abdominal and thoracic aneurysm repair. He has strong interest in the pathophysiology of chronic venous disease and its minimally invasive treatment. Publications include; WOUNDS, Diabetes Care and Annals of Vascular Surgery.
His current basic science research is in the area of the treatment of bio-burden in chronic wounds and intimal response to balloon angioplasty. While the principal investigator on multiple chronic wound trials he has explored the role of various treatments for wound closure; including negative pressure wound therapy, growth factors, and skin substitutes.
His clinical trials interests also include the world of vascular surgery as well where he focuses on topics such as varied as the endovascular treatment of small aortic aneurysms, to novel delivery systems for anti-neointimal hyperplasia agents.
Dr Lantis lectures extensively nationally and internationally on the role of the active agents in the treatment of chronic wounds and the importance of the management of bioburden in limb salvage.